Fulbreca 250mg Injection

Fulbreca 250mg Injection

Fulvestrant

Uses of Fulbreca 250mg Injection

  • Treat Hormone receptor (HR)-positive, human epidermal growth receptor 2 (HER2)-negative breast cancer in postmenopausal women.

Introduction to Fulbreca 250mg Injection

Fulbreca 250mg injection contains the active substance fulvestrant. It is an antineoplastic drug that belongs to the class estrogen receptor antagonist. Estrogen, a type of female sex hormone, can sometimes be involved in the growth of breast cancer. This medicine is used alone to treat postmenopausal women with a certain type of breast cancer called estrogen receptor-positive breast cancer that is locally advanced or spread to other parts of the body. It is also indicated in combination with other anti-cancer medication to treat women with certain types of breast cancer called hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer, which is locally advanced or spread to other parts of the body.

Do not take this injection if you are allergic to fulvestrant or any other ingredients of this medicine, pregnant or breastfeeding, or have severe liver problems. Before initiating the treatment, inform your physician if you have kidney or liver problems, bone diseases, bleeding disorders, and heart diseases. Fulbreca 250mg injection is not indicated in children and adolescents under 18 years. Report to your physician if you have allergic reactions, including swelling of the face, lips, tongue, or throat, after administering this injection.

Common side effects of Fulbreca 250mg injection are pain or inflammation at the site of injection, abnormal levels of liver enzymes, nausea, headache, cough, weakness or tiredness, joint and muscle pain, hot flashes, hair loss, and skin rash. Your doctor may advise you to take certain blood tests while receiving this injection. This injection may increase your risk of bleeding and liver failure. Female patients of reproductive potential should use effective contraception during treatment with this injection and for two years after the last dose.

Therapeutic Effects of Fulbreca 250mg Injection

Many breast cancers have estrogen receptors (ER), and the growth of these tumors can be stimulated by estrogen. Fulbreca 250mg injection is an estrogen receptor antagonist that binds to the estrogen receptors in cancer cells and works by blocking the action of estrogen on cancer cells. This can slow or stop the growth of tumor cells.


Interaction of Fulbreca 250mg Injection with other drugs

Inform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, recent vaccinations, nutritional and vitamin supplements, and herbal products. Certain medications may interact with Fulbreca 250mg injection and reduce its effectiveness by causing undesirable side effects.


More Information about Fulbreca 250mg Injection

  • Store Fulbreca 250mg injection in the refrigerator (2°C to 8°C)
  • Do not freeze
  • keep the injection away from the reach of children and pets.
  • If you have missed any dosing appointments, inform your doctor and schedule immediately.

How to consume Fulbreca 250mg Injection

It should only be administered by a trained doctor or nurse as a slow intramuscular injection. Do not self-administer the injection. Your doctor will decide the dose and duration of the treatment based on your disease severity and other factors.


Safety Advices for Fulbreca 250mg Injection

 

Pregnancy

Fulbreca 250mg injection is unsafe to administer in pregnant women because it may affect the fetus. Inform your physician if you are pregnant, suspect pregnancy, or planning to become pregnant. Using an effective birth control method during the treatment and for 2 years after your last dose is necessary.

 

Breast Feeding

Breastfeeding is not recommended in patients taking Fulbreca 250mg injection because the medicine passes into the breast milk in small amounts and may harm your baby.

 

Lungs

It is unknown whether Fulbreca 250mg injection can be used in patients with lung disorders. Consult your doctor if you have any lung diseases before starting the treatment.

 

Liver

Fulbreca 250mg injection is unsafe when administered in patients with severe liver diseases. Dose adjustments are necessary in moderate liver failure. Inform your physician if you have liver problems before initiating the therapy.

 

Alcohol

Consuming alcohol may affect the effectiveness of the Fulbreca 250mg injection. Stop consuming alcohol if you are taking this medicine.

 

Driving

Fulbreca 250mg injection does not affect the ability to drive. Please consult your doctor for more advice.


Side Effects of Fulbreca 250mg Injection

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.

Common

  • Constipation, diarrhea
  • Loss of appetite
  • Nausea, vomiting
  • Decreased RBC, WBC, and Platelets
  • Infections
  • Joint and muscle pain
  • Backache, bone pain
  • Weakness, tiredness
  • Headache
  • Cough, difficulty breathing
  • Hot flushes
  • Pain at the site of injection

Serious

  • Changes in heart rhythm
  • Severe neutropenia(decreased WBC)
  • Liver failure, inflammation of liver
  • Hypersensitivity reaction
  • Swelling in the body

Brand

RPG Lifescience

Top
× Whatsapp Support?